Literature DB >> 34190345

Lung Pericytes in Pulmonary Vascular Physiology and Pathophysiology.

Ke Yuan1, Stuti Agarwal2, Ananya Chakraborty2, David F Condon2, Hiral Patel2, Serena Zhang2, Flora Huang2, Salvador A Mello2, Obadiah I Kirk3, Rocio Vasquez4, Vinicio A de Jesus Perez2.   

Abstract

Pericytes are mesenchymal-derived mural cells localized within the basement membrane of pulmonary and systemic capillaries. Besides structural support, pericytes control vascular tone, produce extracellular matrix components, and cytokines responsible for promoting vascular homeostasis and angiogenesis. However, pericytes can also contribute to vascular pathology through the production of pro-inflammatory and pro-fibrotic cytokines, differentiation into myofibroblast-like cells, destruction of the extracellular matrix, and dissociation from the vessel wall. In the lung, pericytes are responsible for maintaining the integrity of the alveolar-capillary membrane and coordinating vascular repair in response to injury. Loss of pericyte communication with alveolar capillaries and a switch to a pro-inflammatory/pro-fibrotic phenotype are common features of lung disorders associated with vascular remodeling, inflammation, and fibrosis. In this article, we will address how to differentiate pericytes from other cells, discuss the molecular mechanisms that regulate the interactions of pericytes and endothelial cells in the pulmonary circulation, and the experimental tools currently used to study pericyte biology both in vivo and in vitro. We will also discuss evidence that links pericytes to the pathogenesis of clinically relevant lung disorders such as pulmonary hypertension, idiopathic lung fibrosis, sepsis, and SARS-COVID. Future studies dissecting the complex interactions of pericytes with other pulmonary cell populations will likely reveal critical insights into the origin of pulmonary diseases and offer opportunities to develop novel therapeutics to treat patients afflicted with these devastating disorders. © 2021 American Physiological Society. Compr Physiol 11:2227-2247, 2021.
Copyright © 2021 American Physiological Society. All rights reserved.

Entities:  

Year:  2021        PMID: 34190345     DOI: 10.1002/cphy.c200027

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  4 in total

Review 1.  Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies.

Authors:  Helen Christou; Raouf A Khalil
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-02-25       Impact factor: 4.733

2.  Single Cell Transcriptomic Analysis Reveals Organ Specific Pericyte Markers and Identities.

Authors:  Seung-Han Baek; Enrico Maiorino; Hyunbum Kim; Kimberly Glass; Benjamin A Raby; Ke Yuan
Journal:  Front Cardiovasc Med       Date:  2022-06-01

3.  ACE2 and TMPRSS2 Immunolocalization and COVID-19-Related Thyroid Disorder.

Authors:  Gi-Cheol Park; Hyoun-Wook Lee; Ji-Min Kim; Ji-Min Han; Hye-In Kim; Sung-Chan Shin; Yong-Il Cheon; Eui-Suk Sung; Minhyung Lee; Jin-Choon Lee; Dong-Min Shin; Byung-Joo Lee
Journal:  Biology (Basel)       Date:  2022-04-30

Review 4.  Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.

Authors:  Sarah Halawa; Soni S Pullamsetti; Charles R M Bangham; Kurt R Stenmark; Peter Dorfmüller; Maria G Frid; Ghazwan Butrous; Nick W Morrell; Vinicio A de Jesus Perez; David I Stuart; Kevin O'Gallagher; Ajay M Shah; Yasmine Aguib; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2021-12-06       Impact factor: 49.421

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.